Laurion Capital Management LP - HERON THERAPEUTICS INC ownership

HERON THERAPEUTICS INC's ticker is HRTX and the CUSIP is 427746102. A total of 186 filers reported holding HERON THERAPEUTICS INC in Q3 2022. The put-call ratio across all filers is 0.47 and the average weighting 0.6%.

Quarter-by-quarter ownership
Laurion Capital Management LP ownership history of HERON THERAPEUTICS INC
ValueSharesWeighting
Q4 2022$287,043
-40.4%
114,817
+0.4%
0.00%
-66.7%
Q3 2022$482,000
+5.7%
114,321
+364.3%
0.00%0.0%
Q3 2019$456,000
+111.1%
24,624
+178.0%
0.00%0.0%
Q1 2019$216,000
-92.2%
8,856
-89.8%
0.00%
-88.9%
Q3 2018$2,757,00087,1030.03%
Other shareholders
HERON THERAPEUTICS INC shareholders Q3 2022
NameSharesValueWeighting ↓
TANG CAPITAL MANAGEMENT LLC 8,648,252$238,692,00035.08%
Broadfin Capital, LLC 1,581,416$43,647,0006.80%
Tavio Capital LLC 351,729$9,708,0004.58%
Mesirow Financial Investment Management, Inc. 33,389$922,0003.88%
Rubric Capital Management LP 1,510,008$41,676,0003.88%
KINGDON CAPITAL MANAGEMENT, L.L.C. 1,666,229$45,988,0003.63%
First Light Asset Management, LLC 473,275$13,062,0002.87%
Asymmetry Capital Management, L.P. 77,346$2,135,0002.67%
Copernicus Capital Management, LLC 108,000$2,981,0002.38%
BRIDGER MANAGEMENT, LLC 1,277,560$35,261,0002.14%
View complete list of HERON THERAPEUTICS INC shareholders